Protopic (tacrolimus) 0.1% — CareFirst (Caremark)

Initial criteria

• Requested drug is being prescribed for psoriasis on the face, genitals, or skin folds
• For tacrolimus 0.03% ointment OR tacrolimus 0.1% ointment when patient age ≥ 16 years

Reauthorization criteria

• Patient has achieved or maintained a positive clinical response as evidenced by improvement (e.g., clear or almost clear outcome, patient satisfaction) AND request is for tacrolimus 0.03% ointment OR (tacrolimus 0.1% ointment and patient age ≥ 16 years)

Approval duration

Initial therapy: 3 months; Continuation: 12–36 months depending on reference number; age <2 years: 3 months